Brind.

Stereotaxis announced that David Fischel was appointed Chairman and CEO, and the company filed an offering pursuant to an SEC registration statement.

1 report, 1 independent Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Stereotaxis announced that David Fischel was appointed Chairman and CEO, and the company filed an offering pursuant to an SEC registration statement.

Who's involved

What this event is mainly about
StereotaxisDavid FischelSecurities and Exchange Commission (Bangladesh)

How it developed

Newest first. Tap a step to see who reported it.
  1. Stereotaxis, led by CEO David Fischel, participated in the MAGiC catheter study at Vilnius University Hospital on July 1, 2025.Sub-event
  2. Stereotaxis appointed David Fischel as CEO and filed with the SEC on July 17, 2025.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireStereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock Led by Strategic Industry Partner and Select Institutional Investors Proceeds Strengthen Balance Sheet and Support Comme